Presenting its latest thorough analysis, Future Market Insights (FMI) projects that the global colorectal cancer molecular diagnostics market will grow at an 8% CAGR from its estimated US$ 2.35 billion in 2022 to US$ 5.07 billion by 2032. Rising cancer incidence and improvements in diagnostic labs are driving market expansion. Analysts at FMI have employed in-depth …